Ideaya Biosciences Inc (IDYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 8,038 | 3,544 | 7,880 | 4,022 | 29,699 |
| Gross Profit | 8,038 | 3,544 | 7,880 | 4,022 | 29,699 |
| Operating Expenses | 41,564 | 36,253 | 34,159 | 30,465 | 29,039 |
| Operating Income | -33,526 | -32,709 | -26,279 | -26,443 | 660 |
| Other Income | 6,086 | 4,783 | 2,639 | 2,242 | 955 |
| Pre-tax Income | -27,440 | -27,926 | -23,640 | -24,201 | 1,615 |
| Net Income Continuous | -27,440 | -27,926 | -23,640 | -24,201 | 1,615 |
| Net Income | $-27,440 | $-27,926 | $-23,640 | $-24,201 | $1,615 |
| EPS Basic Total Ops | -0.46 | -0.50 | -0.49 | -0.53 | 0.04 |
| EPS Basic Continuous Ops | -0.46 | -0.50 | -0.49 | -0.52 | 0.04 |
| EPS Diluted Total Ops | -0.46 | -0.50 | -0.49 | -0.53 | 0.04 |
| EPS Diluted Continuous Ops | -0.46 | -0.50 | -0.49 | -0.52 | 0.04 |
| EBITDA(a) | $-35,315 | $-34,644 | $-27,248 | $-25,598 | $1,143 |